Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research focused on Cancer research and Colorectal cancer, with related work in Triple-negative breast cancer, Gemcitabine, Chemoradiotherapy. Notable publications include 'Radiation-induced skin injury: pathogenesis, treatment, and management', 'Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial', and 'A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer'.
Combined Aurora Kinase A and CHK1 Inhibition Enhances Radiosensitivity of Triple-Negative Breast Cancer Through Induction of Apoptosis and Mitotic Catastrophe Associated With Excessive DNA Damage
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer
Radiomic analysis for predicting prognosis of colorectal cancer from preoperative 18F-FDG PET/CT
Radiation-induced skin injury: pathogenesis, treatment, and management
Stanniocalicin 2 Suppresses Breast Cancer Cell Migration and Invasion via the PKC/Claudin-1-Mediated Signaling
Post mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data and acute toxicities
The role of plasma cell-free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patients